We we PRP
aimed aim VBD
in in IN
our we PRP$
study study NN
to to TO
research research VB
the the DT
role role NN
of of IN
new new JJ
cytokines cytokine NNS
such such JJ
as as IN
IL-35 il-35 NN
IL-22 il-22 NN
and and CC
IL-17 il-17 NN
that that WDT
may may MD
form form VB
a a DT
target target NN
for for IN
novel novel JJ
treatment treatment NN
approaches.IL-10 approaches.il-10 NN
IL-17 il-17 NN
TGF-β tgf-β NN
IFN-γ ifn-γ NN
IL-22 il-22 NN
and and CC
IL-35 il-35 NN
serum serum NN
levels level NNS
of of IN
allergic allergic JJ
rhinitis rhinitis NN
-LRB- -lrb- -LRB-
AR ar NN
-RRB- -rrb- -RRB-
patients patient NNS
were be VBD
measured measure VBN
using use VBG
ELISA elisa NN
method method NN
Allergic allergic JJ
sensitization sensitization NN
was be VBD
demonstrated demonstrate VBN
by by IN
the the DT
skin skin NN
prick prick NN
test test NN
Patients patient NNS
only only RB
with with IN
olive olive JJ
tree tree NN
sensitivity sensitivity NN
were be VBD
evaluated evaluate VBN
for for IN
seasonal seasonal JJ
AR ar NN
-LRB- -lrb- -LRB-
SAR sar NN
-RRB- -rrb- -RRB-
Patients patient NNS
only only RB
with with IN
mite mite JJ
sensitivity sensitivity NN
were be VBD
included include VBN
in in IN
the the DT
study study NN
for for IN
perennial perennial JJ
AR ar NNS
-LRB- -lrb- -LRB-
PAR par NN
-RRB- -rrb- -RRB-
AR ar NNS
clinic clinic NN
severity severity NN
was be VBD
demonstrated demonstrate VBN
by by IN
the the DT
nasal nasal JJ
symptom symptom NN
scores score NNS
-LRB- -lrb- -LRB-
NSS nss NNS
-RRB- -rrb- -RRB-
In in IN
total total NN
65 65 CD
AR ar NN
patients patient NNS
-LRB- -lrb- -LRB-
patient patient NN
group group NN
-RRB- -rrb- -RRB-
having have VBG
31 31 CD
PAR par NN
and and CC
34 34 CD
SAR sar NN
patients patient NNS
and and CC
31 31 CD
healthy healthy JJ
individuals individual NNS
-LRB- -lrb- -LRB-
control control NN
group group NN
-RRB- -rrb- -RRB-
participated participate VBD
in in IN
the the DT
study study NN
Cytokine cytokine NN
levels level NNS
between between IN
the the DT
patient patient NN
group group NN
and and CC
the the DT
control control NN
group group NN
were be VBD
compared compare VBN
IL-17 il-17 NN
-LRB- -lrb- -LRB-
p p NN
0.038 0.038 CD
-RRB- -rrb- -RRB-
IL-22 il-22 NN
-LRB- -lrb- -LRB-
p p NN
0.001 0.001 CD
-RRB- -rrb- -RRB-
and and CC
TGF-β tgf-β NN
-LRB- -lrb- -LRB-
p p NN
0.031 0.031 CD
-RRB- -rrb- -RRB-
were be VBD
detected detect VBN
as as RB
high high JJ
in in IN
the the DT
patient patient NN
group group NN
and and CC
IFN-γ ifn-γ NN
-LRB- -lrb- -LRB-
p p NN
< < JJR
0.001 0.001 CD
-RRB- -rrb- -RRB-
was be VBD
detected detect VBN
as as RB
low low JJ
in in IN
the the DT
patient patient NN
group group NN
When when WRB
correlation correlation NN
analysis analysis NN
was be VBD
made make VBN
between between IN
age age NN
gender gender NN
prick prick VB
test test NN
result result NN
NSS NSS NNP
AR ar NN
duration duration NN
and and CC
cytokine cytokine NN
levels level NNS
in in IN
the the DT
patient patient NN
group group NN
a a DT
negative negative JJ
correlation correlation NN
was be VBD
detected detect VBN
only only RB
between between IN
IFN-γ ifn-γ NN
-LRB- -lrb- -LRB-
p p NN
0.032 0.032 CD
/ / :
r r NN
-0.266 -0.266 CD
-RRB- -rrb- -RRB-
level level NN
and and CC
NSS.Accompanied nss.accompanied VBN
by by IN
the the DT
literature literature NN
information information NN
these these DT
results result NNS
made make VBD
us we PRP
think think VB
that that IN
T t NN
cell cell NN
subgroups subgroup NNS
and and CC
cytokines cytokine NNS
have have VBP
an a DT
important important JJ
role role NN
in in IN
AR ar NN
immunopathogenesis immunopathogenesis NN
It it PRP
is be VBZ
thought think VBN
that that IN
future future JJ
studies study NNS
to to TO
be be VB
conducted conduct VBN
relating relate VBG
to to TO
this this DT
subject subject NN
will will MD
form form VB
new new JJ
targets target NNS
in in IN
treatment treatment NN
